Stock Analiz

Ispire Technology Inc. ISPR

Medicinal Chemicals and Botanical Products · IPO 2023 · data as of November 13, 2026

$1.69Market cap $98M
Open the interactive analysis →

Ispire Technology Inc. (ISPR) is a healthcare company listed in the US with a market value of about $98M. In the twelve months to September 30, 2026 it had revenue of $93M and net income of -$36M, a net margin of -39.0%.

Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is track record (1/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -142%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 89% below the current price.

About Ispire Technology

Ispire Technology is listed in the US and classified in medicinal chemicals and botanical products, IPO year 2023. Revenue went from $88M in 2022 to $96M in 2026, growth of about 2.2% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 13% over three years (dilution for shareholders). It spends 0% of revenue on research and development.

Score: 0.6 / 5

Value0/5
Future growth0/5
Track record1/5
Financial health1/5
Shareholder returns1/5

Checks passed

  • ROE above 15%
  • More cash than debt, or low debt to equity
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S1.0
P/B—
EV/EBITDA—
PEG—
Dividend yield—
FCF yield-1.3%
Shareholder yield0.1%
Intrinsic value vs. price−89%

Growth and quality

Revenue growth (1 yr)-24.7%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-16.5%
ROIC (5-yr avg.)-142.2%
Profitable years (of last 10)0
Years paying a dividend2

Financials, last 5 years

Fiscal yearTTM20262025202420232022
Revenue$93M$96M$127M$152M$116M$88M
Net income-$36M-$33M-$39M-$15M-$6M-$2M
Free cash flow-$1M-$875368-$8M-$20M-$9M-$8M
EPS (diluted)$-0.64$-0.58$-0.69$-0.27$-0.12$-0.04
Net margin-39.0%-34.6%-30.8%-9.7%-5.2%-2.1%
ROIC——-523.6%-29.0%-10.0%-6.5%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Ispire Technology stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 89% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Ispire Technology pay a dividend?

Not currently.

Is Ispire Technology a good stock to buy?

We do not give buy or sell advice. Ispire Technology scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.